Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Moodys
AstraZeneca
Johnson and Johnson
Baxter

Last Updated: November 28, 2021

DrugPatentWatch Database Preview

Litigation Details for Eisai Co. Ltd. v. Lupin Ltd. (D. Del. 2013)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in Eisai Co. Ltd. v. Lupin Ltd.
The small molecule drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for Eisai Co. Ltd. v. Lupin Ltd. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-07-24 1 of United States Patent Nos. 6,740,669 (“the ‘669 patent”), 7,750,028 (“the ‘028 patent”) and 8,076,362…FIRST COUNT INFRINGEMENT BY GLENMARK OF U.S. PATENT NO. 6.740.669 22. Plaintiffs re-allege paragraphs 1-21…the ‘362 patent”) (collectively, “the patents-in-suit”). This action arises under the Patent Laws of the…expiration of the ‘669 patent including its patent term extension, would infringe the ‘669 patent under 35 U.S.…copy of the ‘669 patent is attached as Exhibit A. 13. On July 6, 2010, the ‘028 patent, titled “Crystal External link to document
2015-03-17 202 alleging infringement of U.S. Patent Nos. 6,740,669 ("the '669 patent"), 7,750,028 ("the…three patents-in-suit); see also '028 patent at 2:8-9) 3. '362 Patent …pattern" ['669 patent, claim 1; '028 patent, claim 1; '362 patent, claims…;the '028 patent"), and 8,076,362 ("the '362 patent") (collectively, "the…;the patents-in-suit"). Defendants are alleged to infringe the patents-in-suit pursuant to 35 U. External link to document
2013-07-24 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,740,669 B1; 7,750,028 B2; 8,076,362…2013 13 October 2016 1:13-cv-01279 830 Patent None District Court, D. Delaware External link to document
2014-10-17 92 Construction of "Crystal Modification A" in U.S. Patent Nos. 6,740,669, 7,750,028, and 8,076,362 by Lupin Ltd.,…2013 13 October 2016 1:13-cv-01279 830 Patent None District Court, D. Delaware External link to document
2014-10-17 93 of "Sodium Carboxymethycellulose" in U.S. Patent No. 8,076,362 by Lupin Ltd., Lupin Pharmaceuticals Inc…2013 13 October 2016 1:13-cv-01279 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Colorcon
Harvard Business School
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.